Kevin Haynes, PharmD, MSCE

Associate Director of Epidemiology
Johnson & Johnson
Horsham, Pennsylvania, United States

Disclosure information not submitted.

Presentation(s):

• SC-05 - Using pharmacoepidemiology database resources to address drug safety research

  Friday, August 22, 2025
  9:00 AM - 12:30 PM ET

• 5C-02 - Quantitative Bias Analysis to Assess Impact of Outcome Misclassification in a Claims-based COVID-19 Vaccine Safety Study in the US

  Tuesday, August 26, 2025
  8:45 AM - 9:00 AM ET

• 5C-04 - An Observational Postauthorization Safety Study to Assess Adverse Events of Special Interest in Recipients of Ad26.COV2.S in the United States

  Tuesday, August 26, 2025
  9:15 AM - 9:30 AM ET